Advocating for Impact: Drug Pricing in Transition: What’s Ahead for 340B and the IRA
Congress and federal agencies are considering significant changes to the 340B program, while implementation of the Inflation Reduction Act’s Medicare drug price negotiation provisions continues to raise important questions for hospitals and health systems. We’ll provide an update on the latest legislative and regulatory developments, the intersection of IRA implementation and the HRSA 340B rebate pilot, and what to expect from Congress and federal agencies in the months ahead. The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive sour...